Participants were broken into two cohorts. The first cohort received one of three doses of PCRX-201. The second cohort received concurrent pretreatment with an intraarticular corticosteroid ...

today announced that the U.S. Food and Drug Administration (FDA) has issued a “Study Can Proceed” notification for the Company’s Investigational New Drug (IND) application, ARCT-2304, a ...

He long dreamed of working in government, but he and everyone around him felt it wouldn't be possible because of his substance use ... and I think this is a new chapter in the story of the ...

Pacira ended the third quarter of 2024 with cash, cash equivalents and available-for-sale investments (“cash”) of $453.8 million. Cash provided by operations was $53.9 million in the third quarter of ...

A research team led by MedUni Vienna has investigated AC102, a new active substance that offers hope of an effective treatment for acute sudden hearing loss.The latest results have been published ...

The research, which analyzed data from over 15,000 UK cancer patients, identifies ecDNA as a key factor in cancer progression ...

Additionally, CRISP provides a notification service ... the release stated. A new system called the Health Data Utility is ...

DoP rejects Aristo Pharma’s review application for its multivitamin tablets: Gireesh Babu, New Delhi Friday, November 8, 2024, 08:00 Hrs [IST] The Department of Pharmaceuticals ...

Teens turn to drugs for multiple reasons, including to relieve boredom, to feel like an adult, or to fit in.It can also be a ...

Substance Use Treatment Facilities examined data from SAMHSA and other sources to see how teen drug use varies across the U.S ...